Back to Search
Start Over
Frontline treatment approaches in TP53-aberrant mantle cell lymphoma.
- Source :
- Leukemia & Lymphoma; Jan2023, Vol. 64 Issue 1, p230-233, 4p
- Publication Year :
- 2023
-
Abstract
- Patient characteristics. treatment type vs continuous variables using Kruskal-Wallis test and treatment type vs categorical variables using Fisher exact test or chi-square test if applicable. Frontline treatment regimens were grouped by type and intensity: R SP 2 sp , R-CHOP or BR, and high-intensity regimens inclusive of cytarabine or autoHCT. [Extracted from the article]
- Subjects :
- MANTLE cell lymphoma
GRAFT versus host disease
Subjects
Details
- Language :
- English
- ISSN :
- 10428194
- Volume :
- 64
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Leukemia & Lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 161787000
- Full Text :
- https://doi.org/10.1080/10428194.2022.2131407